IOFLUPANE I-123

IOFLUPANE I-123 was reported 545 times

These side effects are most commonly reported by patients taking IOFLUPANE I-123:

# Side effect Count
0 NO ADVERSE EVENT 263
1 RADIOISOTOPE SCAN ABNORMAL 149
2 DRUG INEFFECTIVE 130
3 INJECTION SITE PAIN 59
4 DRUG INTERACTION 49
5 PARKINSONISM 26
6 BURNING SENSATION 24
7 FALSE POSITIVE RADIOISOTOPE INVESTIGATION RESULT 16
8 DOPAMINE TRANSPORTER SCINTIGRAPHY ABNORMAL 13
9 NAUSEA 13
10 HEADACHE 11
11 PRODUCT QUALITY ISSUE 11
12 DIZZINESS 10
13 MALAISE 10
14 PAIN 9
15 FALSE POSITIVE INVESTIGATION RESULT 7
16 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7
17 VOMITING 7
18 FATIGUE 6
19 ABDOMINAL DISCOMFORT 5
20 ERYTHEMA 5
21 FALSE NEGATIVE INVESTIGATION RESULT 5
22 FEELING COLD 5
23 SEIZURE 5
24 BRAIN SCAN ABNORMAL 4
25 DYSGEUSIA 4
26 DYSPNOEA 4
27 HYPERHIDROSIS 4
28 LABELLED DRUG-DRUG INTERACTION ISSUE 4
29 LOSS OF CONSCIOUSNESS 4
30 OROPHARYNGEAL PAIN 4
31 CHEST DISCOMFORT 3
32 DIARRHOEA 3
33 INFUSION RELATED REACTION 3
34 OFF LABEL USE 3
35 PRURITUS 3
36 RASH 3
37 SWELLING 3
38 VISION BLURRED 3
39 ABDOMINAL PAIN 2
40 ANXIETY 2
41 ASTHENIA 2
42 BALANCE DISORDER 2
43 CONTRAST MEDIA ALLERGY 2
44 DRY MOUTH 2
45 DYSKINESIA 2
46 EYE SWELLING 2
47 FEELING ABNORMAL 2
48 FEELING HOT 2
49 HAEMORRHAGIC STROKE 2
50 HYPERKALAEMIA 2
51 HYPOAESTHESIA 2
52 INCORRECT DOSE ADMINISTERED 2
53 PANIC ATTACK 2
54 PNEUMONIA ASPIRATION 2
55 PRESYNCOPE 2
56 RADIOISOTOPE UPTAKE INCREASED 2
57 SOMNOLENCE 2
58 SYNCOPE 2
59 TREMOR 2
60 UNRESPONSIVE TO STIMULI 2
61 VERTIGO 2
62 ABDOMINAL DISTENSION 1
63 ABDOMINAL PAIN UPPER 1
64 ACCIDENTAL EXPOSURE TO PRODUCT 1
65 ACUTE KIDNEY INJURY 1
66 ACUTE PULMONARY OEDEMA 1
67 ADMINISTRATION SITE PAIN 1
68 ANAPHYLACTIC SHOCK 1
69 ANAPHYLACTOID REACTION 1
70 ANGIOEDEMA 1
71 APNOEA 1
72 ARTHRALGIA 1
73 ARTHRITIS 1
74 AURA 1
75 BLISTER 1
76 BLOOD GLUCOSE INCREASED 1
77 BLOOD PRESSURE DECREASED 1
78 BLOOD SODIUM DECREASED 1
79 CARDIO-RESPIRATORY ARREST 1
80 CEREBRAL INFARCTION 1
81 CHILLS 1
82 CHOKING 1
83 DEMENTIA 1
84 DEPRESSED LEVEL OF CONSCIOUSNESS 1
85 DEPRESSION 1
86 DISORIENTATION 1
87 DRUG ADMINISTRATION ERROR 1
88 DYSARTHRIA 1
89 DYSPHAGIA 1
90 ENCEPHALITIS 1
91 EXTRA DOSE ADMINISTERED 1
92 FACIAL PARALYSIS 1
93 FALL 1
94 FLANK PAIN 1
95 FLUSHING 1
96 FORMICATION 1
97 FREEZING PHENOMENON 1
98 GAIT DISTURBANCE 1
99 GLIOBLASTOMA 1
100 HAEMATEMESIS 1
101 HAEMORRHAGE 1
102 HEART RATE DECREASED 1
103 HOT FLUSH 1
104 HYPERSENSITIVITY 1
105 HYPERTENSION 1
106 HYPERTENSIVE CRISIS 1
107 HYPONATRAEMIA 1
108 HYPOTENSION 1
109 ILL-DEFINED DISORDER 1
110 ILLNESS 1
111 INCONTINENCE 1
112 INFLUENZA LIKE ILLNESS 1
113 INHIBITORY DRUG INTERACTION 1
114 INJECTION SITE ERYTHEMA 1
115 INJECTION SITE PARAESTHESIA 1
116 INJECTION SITE PRURITUS 1
117 INJECTION SITE REACTION 1
118 INTRACRANIAL MASS 1
119 IODINE UPTAKE INCREASED 1
120 LYMPHADENOPATHY 1
121 MAGNETIC RESONANCE IMAGING ABNORMAL 1
122 MIGRAINE 1
123 MOTOR DYSFUNCTION 1
124 MUSCLE SPASMS 1
125 MUSCULAR WEAKNESS 1
126 MUSCULOSKELETAL STIFFNESS 1
127 MYOCARDIAL STUNNING 1
128 NECK PAIN 1
129 NERVOUSNESS 1
130 OCCUPATIONAL EXPOSURE TO RADIATION 1
131 OCULAR DISCOMFORT 1
132 OEDEMA 1
133 PARAESTHESIA 1
134 PRODUCT ADMINISTRATION ERROR 1
135 PRODUCT CONTAINER SEAL ISSUE 1
136 PRODUCT SUBSTITUTION ISSUE 1
137 PRURITUS GENERALISED 1
138 PULSE ABSENT 1
139 PYREXIA 1
140 RADIATION OVERDOSE 1
141 RASH ERYTHEMATOUS 1
142 RESPIRATORY ARREST 1
143 RETCHING 1
144 SCAN ABNORMAL 1
145 SENSORY DISTURBANCE 1
146 SINUS DISORDER 1
147 SKIN DISCOLOURATION 1
148 SKIN HYPERTROPHY 1
149 SKIN LESION 1
150 SNEEZING 1
151 SUSPECTED COUNTERFEIT PRODUCT 1
152 SUSPECTED PRODUCT QUALITY ISSUE 1
153 SWELLING FACE 1
154 TENSION HEADACHE 1
155 THERAPEUTIC AGENT-DIAGNOSTIC TEST INTERACTION 1
156 THERAPEUTIC RESPONSE UNEXPECTED 1
157 THROAT TIGHTNESS 1
158 THROMBOPHLEBITIS SUPERFICIAL 1
159 THYROID CANCER 1
160 THYROID PAIN 1
161 TOXIC EPIDERMAL NECROLYSIS 1
162 TYPE IV HYPERSENSITIVITY REACTION 1
163 UNDERDOSE 1